Evidence map›Paper›PMID 24391216›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.

Ning Lu, Lihong Wang, Hailong Cao, Liping Liu, Luc Van Kaer, Mary K Washington, Michael J Rosen, Philip E Dubé, Keith T Wilson, Xiubao Ren and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Morutamins A-L fromACS omega · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in pharmacology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Ning LuDepartment of Breast Cancer Medical Oncology, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, P. R. China;
Lihong Wang
Hailong Cao
Liping Liu
Luc Van Kaer
Mary K Washington
Michael J Rosen
Philip E Dubé
Keith T Wilson
Xiubao Ren
Xishan Hao
D Brent Polk
Fang Yan
Vanderbilt University Medical Center · USTianjin Medical University Cancer Institute and Hospital · CNChildren's Hospital of Los Angeles · USUniversity of Southern California · USVA Tennessee Valley Healthcare System · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 2009 to 2026
$27.5M
CYTOKINE REGULATION OF INTESTINAL EPITHELIAL RESTITUTIONR01DK056008 · NIDDK · VANDERBILT UNIVERSITY · PI POLK, D BRENT · 1999 to 2020
$6.8M
Regulation of intestinal development by a Lactobacillus GG-derived proteinR01DK081134 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI YAN, FANG · 2009 to 2023
$4.7M
Immunomodulatory effects of arginine supplementation in colitis and colon cancerR01AT004821 · NCCIH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 2008 to 2017
$4.0M
HPYLORI INDUCED DNA DAMAGE AND IMMUNE DYSREGULATIONR01DK053620 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1997 to 2014
$3.4M
REGULATION OF INTESTINAL EPITHELIAL CELL MIGRATIONR01DK054993 · NIDDK · VANDERBILT UNIVERSITY · PI POLK, D. BRENT · 2001 to 2005
$1.1M
Th2 Cytokines and Signaling in Pediatric Inflammatory Bowel DiseaseK23DK094832 · NIDDK · VANDERBILT UNIVERSITY · PI ROSEN, MICHAEL J · 2013 to 2017
$900k
Arginine Availability and Metabolism in the Immune Evasion of H. pyloriI01BX001453 · VA · VETERANS HEALTH ADMINISTRATION · PI WILSON, KEITH T. · 2012 to 2019
–
BLRD VA I01 BX001453NCCIH NIH HHS R01 AT004821NCI NIH HHS P01 CA116087NCI NIH HHS P01CA116087NIDDK NIH HHS K23 DK094832NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30DK058404NIDDK NIH HHS R01 DK053620NIDDK NIH HHS R01 DK054993NIDDK NIH HHS R01DK054993NIDDK NIH HHS R01 DK056008NIDDK NIH HHS R01DK056008NIDDK NIH HHS R01 DK081134NIDDK NIH HHS R01DK081134
6 · The paper itself

Abstract

Macrophages regulate innate immunity to maintain intestinal homeostasis and play pathological roles in intestinal inflammation. Activation of the epidermal growth factor receptor (EGFR) promotes cellular proliferation, differentiation, survival, and wound closure in several cell types. However, the impact of EGFR in macrophages remains unclear. This study was to investigate whether EGFR activation in macrophages regulates cytokine production and intestinal inflammation. We found that EGFR was activated in colonic macrophages in mice with dextran sulfate sodium (DSS)-induced colitis and in patients with ulcerative colitis. DSS-induced acute colitis was ameliorated, and recovery from colitis was promoted in Egfr(fl/fl)LysM-Cre mice with myeloid cell-specific deletion of EGFR, compared with LysM-Cre mice. DSS treatment increased IL-10 and TNF levels during the acute phase of colitis, and increased IL-10 but reduced TNF levels during the recovery phase in Egfr(fl/fl)LysM-Cre mice. An anti-IL-10 neutralizing Ab abolished these effects of macrophage-specific EGFR deletion on DSS-induced colitis in Egfr(fl/fl)LysM-Cre mice. LPS stimulated EGFR activation and inhibition of EGFR kinase activity enhanced LPS-stimulated NF-κB activation in RAW 264.7 macrophages. Furthermore, induction of IL-10 production by EGFR kinase-blocked RAW 264.7 cells, in response to LPS plus IFN-γ, correlated with decreased TNF production. Thus, although selective deletion of EGFR in macrophages leads to increases in both pro- and anti-inflammatory cytokines in response to inflammatory stimuli, the increase in the IL-10 level plays a role in suppressing proinflammatory cytokine production, resulting in protection of mice from intestinal inflammation. These results reveal an integrated response of macrophages regulated by EGFR in intestinal inflammatory disorders.

Indexed as

AdolescentAdultAgedAnimalsCell LineColitisColitis, UlcerativeColonCyclooxygenase 2CytokinesDextran SulfateErbB ReceptorsFemaleGene Expression RegulationHumansImmunity, InnateCyclooxygenase 2CytokinesDextran SulfateEGFR protein, humanEGFR protein, mouseErbB ReceptorsIL10 protein, mouseInterferon-gammaInterleukin-10LipopolysaccharidesNF-kappa BPtgs2 protein, mouseQuinazolinesRTKI cpdTumor Necrosis Factor-alphaTyrphostins

Identifiers

PMID24391216
PMCPMC4006992
OpenAlexW1927056728

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.